FDA approves Teva's generic EpiPen after yearslong delay
Teva Announces FDA Acceptance of Resubmitted New Drug Application for SD-809 for Treatment of Chorea Associated with Huntington Disease - Huntington's Disease News
Teva recalls U.S.-made drugs following contamination fears | Pittsburgh Post-Gazette
FDA accepts Teva new drug resubmission - Globes
Teva's troubled Godollo plant earns firm US FDA warning letter
Teva Shares Rise Following FDA Approval of Migraine Drug | Ctech
FDA swats down Teva's EpiPen copy, putting Mylan in cruise control | Fierce Pharma
Teva Pharmaceuticals - pdf download
Will Teva Pharmaceutical Strengthen Specialty Pipeline in 3Q16?
FDA approves first generic version of epilepsy drug Sabril from Teva
Teva halts production at sterile injectables plant to address FDA concerns | Fierce Pharma